AriasF., DuenasM., MartinezE.: Radical chemotherapy for elderly patients with bladder carcinoma invading muscle. Cancer, 80: 115–120, 1997.
2.
BalducciM., ExtermannM.: Management of cancer in the older person: a practcal approach. Oncologist, 5: 224–237, 2000.
3.
BastionY., BlayJ.Y., DivineM.: Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and srvival – a Grouped'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years. J Clin Oncol, 15: 2945–2953, 1997.
4.
GomezH., HidalgoM., CasanovaL.: Risk factor for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis. J Clin Oncol, 16: 2065–2069, 1998.
5.
IbrahimN.K., FryeDk, BuzdarA.U.: Doxorubicin-based chemotherapy in elderly patients with metastatic breast cancer. Tolerance and outcome. Arch Inter Med, 156: 882–888, 1996.
6.
MeyerR.M., BrowmanG.P., SamoshM.L., BengerA.M., Bryant-LukosiusD., WilsonW.E., FrankG.L., LeberB.F., SternbachM.S., FosterG.A.: Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma. J Clin Oncol, 13: 2386–2393, 1995.
7.
SonneveldP., De RidderM., Van der LelieH., NieuwenhuisK., SchoutenH., MulderA., van ReijswoudI., HopW., LowenbergB.: Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapyJ Clin Oncol, 13: 2530–2539, 1995.
8.
TirelliU., ZagonelV., SerrainoD., ThomasJ., HoerniB., Tan-guryA., RuhlU., BeyP., TubianaN., BreedW.P.: Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study. J Clin Oncol, 6: 1708–1713, 1988.
9.
TirelliU., ZagonelV., ErranteD., FratinoL., MonfardiniS.: Treatment of non-Hodgkin's lymphoma in the elderly: an update. Hematol Oncol, 16: 1–13, 1998.
10.
TirelliU., ErranteD., Van GlabbekeM., TeodorovicI., Kluin-NelemansJ.C., ThomasJ., BronD., RostiG., SomersR., ZagonelV., NoordijkE.M.: CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol, 16: 27–34, 1998.
